Intra-Cellular Therapies
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Option
VANOVER KIMBERLY E. officer: SVP, Early Stage Clini..
Common Stock 18,750 $1.45 $27,244
Option
VANOVER KIMBERLY E. officer: SVP, Early Stage Clini..
Stock Option (right to buy) 5,000 N/A N/A
Purchase
ALAFI MOSHE 10 percent owner
Common Stock 20,826 N/A N/A
Purchase
ALAFI CAPITAL CO LLC 10 percent owner
Common Stock 20,826 N/A N/A
Purchase
ALAFI CHRISTOPHER D director
Common Stock 20,826 N/A N/A
Purchase
ALAFI CHRISTOPHER D director
Common Stock 44,174 N/A N/A
Purchase
ALAFI CAPITAL CO LLC 10 percent owner
Common Stock 44,174 N/A N/A
Purchase
ALAFI MOSHE 10 percent owner
Common Stock 44,174 N/A N/A
Option
DAVIS ROBERT E officer: SVP, Chief Scientific ..
Restricted Stock Units 1,757 N/A N/A
Option
DAVIS ROBERT E officer: SVP, Chief Scientific ..
Common Stock 1,757 N/A N/A
Purchase
ALAFI MOSHE 10 percent owner
Common Stock 34,000 N/A N/A
Purchase
ALAFI CHRISTOPHER D director
Common Stock 34,000 N/A N/A
Purchase
ALAFI CAPITAL CO LLC 10 percent owner
Common Stock 34,000 N/A N/A
Purchase
ALAFI CHRISTOPHER D director
Common Stock 100,000 N/A N/A
Option
LERNER RICHARD A director
Stock Option (right to buy) 10,000 N/A N/A
Option
LERNER RICHARD A director
Common Stock 10,000 N/A N/A
Sale
HINELINE LAWRENCE J. officer: SVP of Finance CFO
Common Stock 22,500 N/A N/A
Sale
HINELINE LAWRENCE J. officer: SVP of Finance CFO
Common Stock 22,500 $51.97 $1,169,213
Option
HINELINE LAWRENCE J. officer: SVP of Finance CFO
Stock Option (right to buy) 12,500 N/A N/A
Option
HINELINE LAWRENCE J. officer: SVP of Finance CFO
Common Stock 25,000 $1.5 $37,500
Option
HINELINE LAWRENCE J. officer: SVP of Finance CFO
Common Stock 25,000 N/A N/A
Sale
HINELINE LAWRENCE J. officer: SVP of Finance CFO
Common Stock 22,500 N/A N/A
Option
HINELINE LAWRENCE J. officer: SVP of Finance CFO
Common Stock 7,500 N/A N/A
Option
HINELINE LAWRENCE J. officer: SVP of Finance CFO
Stock Option (right to buy) 7,500 N/A N/A
Option
MATES SHARON director, officer: Chairman, Pr..
Common Stock 68,750 N/A N/A
Option
MATES SHARON director, officer: Chairman, Pr..
Common Stock 68,750 $0.9 $61,875
Option
MATES SHARON director, officer: Chairman, Pr..
Stock Option (right to buy) 43,750 $1.05 $45,938
Option
MATES SHARON director, officer: Chairman, Pr..
Stock Option (right to buy) 43,750 N/A N/A
Sale
MATES SHARON director, officer: Chairman, Pr..
Common Stock 51,500 N/A N/A
Sale
MARCUS JOEL S director
Common Stock 22,700 N/A N/A
Sale
MARCUS JOEL S director
Common Stock 40,000 N/A N/A
Sale
MARCUS JOEL S director
Common Stock 30,000 N/A N/A
Option
HINELINE LAWRENCE J. officer: SVP of Finance CFO
Stock Option (right to buy) 5,000 N/A N/A
Option
HINELINE LAWRENCE J. officer: SVP of Finance CFO
Common Stock 5,000 N/A N/A
Sale
HINELINE LAWRENCE J. officer: SVP of Finance CFO
Common Stock 5,000 N/A N/A
Option
FIENBERG ALLEN A. officer: VP of Business Develop..
Common Stock 12,500 N/A N/A
Option
FIENBERG ALLEN A. officer: VP of Business Develop..
Stock Option (right to buy) 12,500 N/A N/A
Sale
FIENBERG ALLEN A. officer: VP of Business Develop..
Common Stock 200 N/A N/A
Sale
FIENBERG ALLEN A. officer: VP of Business Develop..
Common Stock 10,000 N/A N/A
Sale
WENNOGLE LAWRENCE P. officer: Vice President, Drug D..
Common Stock 25,000 N/A N/A
Option
WENNOGLE LAWRENCE P. officer: Vice President, Drug D..
Common Stock 47,500 N/A N/A
Option
WENNOGLE LAWRENCE P. officer: Vice President, Drug D..
Stock Option (right to buy) 12,500 N/A N/A
Option
WENNOGLE LAWRENCE P. officer: Vice President, Drug D..
Common Stock 47,500 $0.83 $39,188
Option
FIENBERG ALLEN A. officer: VP of Business Develop..
Common Stock 12,500 N/A N/A
Option
FIENBERG ALLEN A. officer: VP of Business Develop..
Stock Option (right to buy) 12,500 N/A N/A
Option
MARCUS JOEL S director
Stock Option (right to buy) 5,000 N/A N/A
Option
MARCUS JOEL S director
Common Stock 15,000 N/A N/A
Option
MARCUS JOEL S director
Common Stock 15,000 $1.16 $17,400
Purchase
ALAFI CHRISTOPHER D director
Common Stock 625,000 N/A N/A
Purchase
SOSLAND MORTON I. 10 percent owner
Common Stock 250,000 N/A N/A

Showing 700 to 750 of 805 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.